These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16493382)

  • 1. [Obesity and the heart].
    Barzizza F
    Minerva Gastroenterol Dietol; 2001 Dec; 47(4):229-34. PubMed ID: 16493382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obesity and cardiac failure].
    Galinier M; Pathak A; Roncalli J; Massabuau P
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):39-45. PubMed ID: 15724418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and the heart.
    Alpert MA; Hashimi MW
    Am J Med Sci; 1993 Aug; 306(2):117-23. PubMed ID: 8362892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamics of massive obesity].
    Valensi P
    Rev Prat; 1993 Oct; 43(15):1918-23. PubMed ID: 8310245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non invasive quantification of the parietal systolic stress of the left ventricle in patients with heart failure and its clinical application].
    Guadalajara Boo JF; González Zárate J; Bucio Reta E; Pérez P; Cué Carpio RJ
    Arch Cardiol Mex; 2007; 77(2):120-9. PubMed ID: 17715625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac function in massively obese patients and the effect of weight loss.
    Herrera MF; Deitel M
    Can J Surg; 1991 Oct; 34(5):431-4. PubMed ID: 1913384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of obesity and weight loss on cardiac performance and morphology in adults.
    Alpert MA; Omran J; Mehra A; Ardhanari S
    Prog Cardiovasc Dis; 2014; 56(4):391-400. PubMed ID: 24438730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes mellitus, left ventricular dysfunction and congestive heart failure].
    Tarantini L; Di Lenarda A; Velussi M; Faggiano P; Comaschi M; Faglia E; Maggioni AP
    Ital Heart J Suppl; 2004 Aug; 5(8):605-15. PubMed ID: 15554015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, heart failure and sudden death.
    Contaldo F; Pasanisi F; Finelli C; de Simone G
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):190-7. PubMed ID: 12514939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V; Kes P; Reiner Z
    Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B; Petrović D; Obrenović R
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension and obesity].
    Raison J; Pannier B; Blacher J; Safar M
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1423-8. PubMed ID: 11190291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Corrao G; Trevano FQ; Giannattasio C; Grassi G; Sega R
    J Hypertens; 2008 Aug; 26(8):1602-11. PubMed ID: 18622239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of obesity and consequent insulin resistance on coronary risk factors in medically treated patients with coronary disease.
    Ades PA; Savage PD; Toth MJ; Schneider DJ; Audelin MC; Bunn JY; Ludlow M
    Int J Obes (Lond); 2008 Jun; 32(6):967-74. PubMed ID: 18268512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance.
    Perseghin G; Ntali G; De Cobelli F; Lattuada G; Esposito A; Belloni E; Canu T; Costantino F; Ragogna F; Scifo P; Del Maschio A; Luzi L
    Diabetes Care; 2007 Jun; 30(6):1520-6. PubMed ID: 17384336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population.
    Azevedo A; Bettencourt P; Almeida PB; Santos AC; Abreu-Lima C; Hense HW; Barros H
    BMC Cardiovasc Disord; 2007 Jun; 7():17. PubMed ID: 17555566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and cardiomyopathy in obesity. Treat the heart simultaneously].
    Wirth A
    MMW Fortschr Med; 2001 Oct; 143(42):39-42. PubMed ID: 11697285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.